Dr. Joonsu Han | Immunoengineering | Young Scientist Award

Postdoctoral Appointee, Argonne National Laboratory, United States

Joonsu Han is a skilled researcher specializing in biomaterials and cancer immunotherapy. He is currently a Postdoctoral Appointee at Argonne National Laboratory, Illinois, focusing on cutting-edge research in bioengineering and immuno-oncology. His academic journey started with a Bachelor’s degree in Materials Science and Engineering with Highest Honors from Georgia Institute of Technology, followed by a Ph.D. candidate position at the University of Illinois, Urbana-Champaign. Joonsu’s work spans advanced biomaterials, immunotherapy, and metabolic engineering to enhance dendritic cell vaccines, making significant contributions to cancer treatment.

Publication Profile

Google Scholar

Education

Joonsu Han holds a B.S. in Materials Science and Engineering with Highest Honors from the Georgia Institute of Technology (2017). He is currently a Ph.D. candidate at the University of Illinois, Urbana-Champaign, where he is set to complete his doctoral studies in 2024. Additionally, Joonsu is a Cancer Scholars for Translational and Applied Research (C☆STAR) Trainee at the Cancer Center at Illinois, further enhancing his expertise in cancer research.

Experience

Joonsu’s experience spans across several prestigious institutions, including his current role as a Postdoctoral Appointee at Argonne National Laboratory. He also completed a C☆STAR program Trainee position at the Cancer Center at Illinois. During his Ph.D. research, Joonsu contributed to a wide range of innovative cancer immunotherapy projects, including enhancing dendritic cell functionality for vaccine development and creating bio-adhesive hydrogels for in situ immune cell recruitment. His previous research experience at Georgia Tech focused on cardiac regenerative materials.

Awards and Honors

Joonsu has received several awards throughout his academic journey, including the Fall 2022 Conference Presentation Award from the Graduate College at UIUC and the prestigious C STAR Award from the Cancer Center at Illinois. He has also been recognized for his conference presentations and his innovative work in cancer immunotherapy and biomaterials.

Research Focus

Joonsu Han’s research focuses on cancer immunotherapy and the development of novel biomaterials to enhance the efficacy of cancer treatments. His work with dendritic cell vaccines, self-adjuvanting mRNA vaccines, and advanced bio-adhesive hydrogels aims to improve tumor-targeted therapies and immune cell modulation. Joonsu is particularly interested in utilizing metabolic glycoengineering and other biotechnological approaches to optimize dendritic cell functionality for improved antitumor efficacy.

Conclusion

Joonsu Han is a promising researcher whose work in cancer immunotherapy and biomaterial design is paving the way for innovative treatments. His expertise in advanced materials, cell-based assays, and immunoengineering continues to have a significant impact on the field. With numerous peer-reviewed publications and awards, Joonsu’s contributions to medical research are poised to benefit cancer patients worldwide.